يعرض 1 - 20 نتائج من 21,342 نتيجة بحث عن '(( significantly decreased decrease ) OR ( significantly ((small decrease) OR (marked decrease)) ))', وقت الاستعلام: 0.49s تنقيح النتائج
  1. 1
  2. 2
  3. 3

    Cinacalcet administered early in the inactive phase markedly decrease parathyroid Ki-67 index. حسب Søren Egstrand (10906087)

    منشور في 2025
    "…All groups were compared by Kruskal Wallis test with <i>post hoc</i> test after Dunn with Bonferroni adjustment showing significant decreased Ki-67 labeling index of <i>Cina1</i> compared to <i>Cina2</i> (p = 0.006) and the untreated CKD groups (p = 0.0001 and p = 0.0002, respectively). …"
  4. 4
  5. 5

    Significantly Enriched Pathways. حسب Jiyong Zhang (2498740)

    منشور في 2025
    الموضوعات:
  6. 6

    Metabolites with decreasing levels during the development. حسب Martin Sládek (130663)

    منشور في 2025
    "…<p>Temporal profiles of polar metabolites and lipids with SCN levels significantly decreasing from E19 to P28. Rhythmicity was determined by eJTK; full or dashed lines depict the profiles that either did or did not pass the significance threshold (FDR-adjusted <i>P</i> < 0.05), respectively.…"
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13

    Decreased clonogenic capacity of U87MG and U251MG glioma cells dependent on SHG-44 concentration. حسب Denis Mustafov (19137870)

    منشور في 2025
    "…<p><b>(A)</b> A significant decrease in the proliferative clonal capacity of U87MG colonies was observed with 70ΜM and 100ΜM SHG-44 treatment. …"
  14. 14
  15. 15
  16. 16

    <b>The loss of insulin-positive cell clusters precedes the decrease of islet frequency and beta cell area in type 1 diabetes</b> حسب Denise M. Drotar (21679539)

    منشور في 2025
    "…Moreover, changes in endocrine composition also occurred in mAAb+ donors, including a significant decrease in the INS+ islet fraction. These data suggest preferential loss of INS+ small endocrine objects early in type 1 diabetes development.…"
  17. 17

    Significant condition. حسب Junxia Zhou (14381598)

    منشور في 2024
    الموضوعات:
  18. 18
  19. 19
  20. 20

    Evogliptin attenuates the phenotypic switch of VSMCs during CER treatment by decreasing the osteogenesis-associated genes <i>in-vitro.</i> حسب Razia Rashid Rahil (22772495)

    منشور في 2025
    "…(B, C) Summarized bar graph showed EVO significantly decreased calcium deposition and calcium content in CER treated P<sub>i</sub>-induced VSMCs. …"